Angola Pharmaceuticals & Healthcare Q4 2018
The Angolan economy is set to recover from a prolonged downturn which has inhibited the government’s abilitydevelop a robust system for buying and distributing medicines or training doctors and nurses, weakening the pharmaceutical andhealthcare sectors. Angola’s new President, João Lourenço, has pledged to combat corruption, attract foreign investment andimprove healthcare services. However, we continue to view Angola as one of the least attractive markets multinational drugmakersin the region given its small size, low per capita spending and weak regulatory environment.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook